Recensioni verificate Soddisfatta del servizio.
Personale disponibile e gentile. Lo consiglio a tutti ...
Cliente Sorgente Genetica
logomysorgente

02  4948  5291

  • Cos'è AURORA

    Aurora è il test di screening prenatale di ultima generazione 
    sicuro, affidabile,
    veloce e precoce

  • Sicuro

    Grazie a un semplice prelievo di sangue materno
    eviti il rischio di aborto di tecniche invasive come amniocentesi o villocentesi

  • Affidabile

    Oltre il 99,9% di affidabilità nel rilevare
    la trisomia 21, responsabile
    della Sindrome di Down

  • Precoce e veloce

    icona svegliaIndividuare precocemente la presenza di anomalie cromosomiche è fondamentale:
    puoi effettuare Aurora dalla 10ª settimana

    icona documentoIl test è veloce: risultati in 7-10 giorni lavorativi con la percentuale di test da ripetere più bassa del mercato: 0,1%

  • La serenità della mamma
    in 3 semplici passi

    icotelefona

    Prenota il test

    icoesami

    Fai un prelievo di sangue

    icoginecologo

    Leggi i risultati

  • Test diagnosi prenatale non invasivo
  • 151126 banner Aurora mobile 01
  • 151126 banner Aurora mobile 02
  • 151126 banner Aurora mobile 03
  • slide mobile03
cover cartoon
cover venturetti

Ultime notizie dal mondo della genetica


The genetic cause of a rare metabolic disease has been identified

An international team of researchers has identified a rare genetic mutation, the cause of an inherited metabolic disease. The mutation has been found in the DNA of three children with degenerative diseases, without diagnosis. Although the gene is intact, it is repeated so many times that it is in fact unusable.

A phenomenon that is impossible to detect, except with whole-genome sequencing. At first, the researchers led by Dr. van Karnebeek failed to identify the genetic variant. The BC Children's team then intervened with a whole new approach. Scientists used manual analysis and combined bioinformatics tools. In this way they were able to identify the repetitions that prevent the gene from functioning. A discovery also possible thanks to a multidisciplinary approach.

The identified gene encodes the enzyme that regulates the glutamate-glutamine cycle. It is not yet clear how the anomaly causes the disease. It is likely to be the fault of excess glutamine or glutamate deficiency. The discovery finally provided a diagnosis to the three children and their families. Above all, it opens the door to the development of possible treatments even for more common diseases. Further research will be needed to develop gene or drug therapy.

To combat the effects of metabolic disease, dietary changes and dietary supplements may also be needed. All in order to slow down or even stop the damage caused by the disease.

Source: ubc.ca

Link social

Link social